Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.

Nieves Fernández-Arcás, Asunción Blanco, M Jesús Gaitán, Maria Nyqvist, Antonio Alonso, Armando Reyes-Engel
{"title":"Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.","authors":"Nieves Fernández-Arcás,&nbsp;Asunción Blanco,&nbsp;M Jesús Gaitán,&nbsp;Maria Nyqvist,&nbsp;Antonio Alonso,&nbsp;Armando Reyes-Engel","doi":"10.1097/00008571-200403000-00007","DOIUrl":null,"url":null,"abstract":"<p><p>Levels of myxovirus resistance protein A (MxA) mRNA were studied for a single nucleotide polymorphism in the promoter region at nucleotide position -88 of the gene to identify individual-specific responses to interferon (IFN)-alpha2 that might predict responsiveness to IFN-alpha therapy. We quantified MxA expression by reverse transcription and real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMC) in vitro, induced by IFN-alpha2, from 22 healthy donors, in relation with G/T polymorphism located in the promoter of the MxA. MxA mRNA was significantly upregulated in all subjects (mean of 53-fold) in response to IFN-alpha2 in vitro (P < 0.01). Comparison of the inducibility of MxA mRNA expression in relation with G/T polymorphism showed a 4.26-fold higher induction of MxA mRNA levels in PBMC from carriers of the mutant allele (GT or TT) than homozygotes with the wild-type allele (GG) (P < 0.001). We propose that expression of the IFN-inducible MxA is affected by a single nucleotide polymorphism in the MxA promoter which can identify an individual response to IFN-alpha2.</p>","PeriodicalId":19917,"journal":{"name":"Pharmacogenetics","volume":"14 3","pages":"189-93"},"PeriodicalIF":0.0000,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00008571-200403000-00007","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/00008571-200403000-00007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

Levels of myxovirus resistance protein A (MxA) mRNA were studied for a single nucleotide polymorphism in the promoter region at nucleotide position -88 of the gene to identify individual-specific responses to interferon (IFN)-alpha2 that might predict responsiveness to IFN-alpha therapy. We quantified MxA expression by reverse transcription and real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMC) in vitro, induced by IFN-alpha2, from 22 healthy donors, in relation with G/T polymorphism located in the promoter of the MxA. MxA mRNA was significantly upregulated in all subjects (mean of 53-fold) in response to IFN-alpha2 in vitro (P < 0.01). Comparison of the inducibility of MxA mRNA expression in relation with G/T polymorphism showed a 4.26-fold higher induction of MxA mRNA levels in PBMC from carriers of the mutant allele (GT or TT) than homozygotes with the wild-type allele (GG) (P < 0.001). We propose that expression of the IFN-inducible MxA is affected by a single nucleotide polymorphism in the MxA promoter which can identify an individual response to IFN-alpha2.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多态黏液病毒抗性蛋白A对干扰素治疗反应的差异转录expresión
研究黏液病毒耐药蛋白A (MxA) mRNA的水平,以确定对干扰素(IFN)- α 2的个体特异性反应,从而可能预测对IFN- α治疗的反应。我们利用IFN-alpha2诱导的体外外周血单核细胞(PBMC),通过逆转录和实时聚合酶链反应,定量测定了MxA启动子G/T多态性与MxA表达的关系。所有受试者的MxA mRNA在体外对IFN-alpha2的反应中均显著上调(平均上调53倍)(P < 0.01)。与G/T多态性相关的MxA mRNA表达诱导率比较显示,突变等位基因(GT或TT)携带者对PBMC中MxA mRNA表达的诱导率比与野生型等位基因(GG)纯合子高4.26倍(P < 0.001)。我们提出ifn诱导的MxA的表达受到MxA启动子的单核苷酸多态性的影响,该启动子可以识别对IFN-alpha2的个体反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
In Silico Studies on Pharmacokinetics and Neuroprotective Potential of 25Mg2+: Releasing Nanocationites - Background and Perspectives Introductory Chapter: Pharmacogenetics Pharmacogenomics of “Core” Essential Medicines Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients. The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1